Cambridge Team's AI Vaccine Passes First Human Trial

A Cambridge-developed AI vaccine targeting shared features across coronavirus families has passed a phase I safety trial, with a phase II study now planned.
Press Association

source https://www.medscape.com/s/viewarticle/cambridge-teams-ai-vaccine-passes-first-human-trial-2026a1000iyl?src=rss